Innovative Technology from University of Gdańsk Helps Develop COVID-19 Vaccine
Credit: Fotolia
Scientists from Gdańsk have developed an innovative technology that will help create next generation recombinant vaccines to be used in the battle against COVID-19.
The team from the University of Gdańsk and biotech company BioVentures said the technology is based on building artificial proteins that can be used to create the vaccines.
According to the WTS Patent Attorneys, who are dealing with the legal protection of the technology, it “could be used to obtain a vaccine against the SARS-Cov-2 coronavirus strain that causes COVID-19, and inhibitory drugs that stop the virus from developing in an infected person.”
The company added: "The patented invention is suitable for the production of improved next generation vaccines with increased efficiency, including those used to combat viral and bacterial infections as well as cancer cells.”
The originator and main co-founder of the company is Professor Piotr Skowron, head of the Department of Molecular Biotechnology at the Faculty of Chemistry of the University of Gdańsk.
He has now been invited to take part in a consortium set up by the EU for combating the coronavirus.
(PAP)
Author: Anna Kisicka
aks/ mhr/ kap/
tr. RL
Przed dodaniem komentarza prosimy o zapoznanie z Regulaminem forum serwisu Nauka w Polsce.
